Job Summary
IDEAYA is a precision medicine oncology company committed to the discovery, development, and commercialization of transformative therapies for cancer. Our approach integrates expertise in small‑molecule drug discovery, structural biology and bioinformatics with robust internal capabilities in identifying and validating translational biomarkers to develop tailored, potentially first‑in‑class targeted therapies aligned to the genetic drivers of disease. We have built a deep pipeline of product candidates focused on synthetic lethality and antibody‑drug conjugates, or ADCs, for molecularly defined solid tumor indications. Our mission is to bring forth the next wave of precision oncology therapies that are more selective, more effective, and deeply personalized with the goal of altering the course of disease and improving clinical outcomes for patients with cancer.
When you’re at IDEAYA, you will be in the midst of brilliant minds working on precision medicine therapies to help cancer patients. We are passionate and committed about being on the forefront of oncology medicine, which means we all have a high internal drive that is at the very core of every person at IDEAYA. We are inquisitive, ask deep questions, and are data‑driven innovators who like to collaborate and use team work to move science forward. For more information, please see
Position Summary
We are seeking a Director, ADC MSAT who will have responsibility for managing development, technology transfer, manufacturing, and BLA/launch preparation activities at CDMOs for IDEAYA’s antibody‑drug conjugate (ADC) platform and pipeline. This role will be an integral part of a team built to execute the CMC strategy required to advance ADC programs through clinical development and successfully enable global commercial launch and post‑approval supply. The position requires a seasoned Development/MSAT professional with technical experience in antibody/ADC development, capable of collaborating effectively with internal and external subject matter experts. The successful candidate has strong execution capability across clinical and commercial stages, and experience operating within a predominantly outsourced manufacturing model while supporting the development of scalable internal capabilities.
This position is based in our South San Francisco headquarters and is required to be onsite four days per week in accordance with our company policy.
Reporting to: Vice President, Antibody Drug Conjugate (ADC) Development and Manufacturing.
Location: South San Francisco, CA.
#J-18808-Ljbffr